
At Kodak's Rochester facility, the company is now producing a Class 1 pharmaceutical product, a phosphate-buffered saline solution, for research and hospitals. While Kodak continues to manufacture film, which remains its largest revenue generator, the CEO emphasizes a new strategy of diversification away from reliance on a single product.